A CD40LG-Centered 6-Gene Risk Model for Survival Stratification and Immunotherapy Benefit Prediction in Ovarian Cancer

Yuan Gao, Mingxia Ye, Yawen Wu, Liang Wen, Li-An Li, Yuanguang Meng

PDF(38450 KB)
For Authors|For Editors|For Reviewers
PDF(38450 KB)
Discovery Medicine ›› 2026, Vol. 38 ›› Issue (207) : 1115-1130. DOI: 10.24976/Discov.Med.202638207.90
Article

A CD40LG-Centered 6-Gene Risk Model for Survival Stratification and Immunotherapy Benefit Prediction in Ovarian Cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

Highlight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2026, 38(207): 1115-1130 https://doi.org/10.24976/Discov.Med.202638207.90

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(38450 KB)

Accesses

Citation

Detail
Sections
Recommended
Follow Us on
Copyright © 2026.
By using this website, you agree to our Terms & Conditions and Privacy Policy.  
  • Disclaimer
    The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    • /

    〈 〉